{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:22Z","timestamp":1792782502945,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhuhai Medical Research Project","award":["2520009000044"],"award-info":[{"award-number":["2520009000044"]}]},{"name":"Research Project Established by Chinese Pharmaceutical Association Hospital Phamacy Department","award":["CPA-Z05-ZC-2025002"],"award-info":[{"award-number":["CPA-Z05-ZC-2025002"]}],"id":[{"id":"https:\/\/ror.org\/023q20n38","id-type":"ROR","asserted-by":"crossref"}]},{"name":"China Higher Education Institution Industry-University-Research Innovation Fund","award":["2025XH101"],"award-info":[{"award-number":["2025XH101"]}]},{"name":"Research project on high quality development of Hospital pharmacy, National Institute of Hospital Administration, NHC, China","award":["NIHAYS2505"],"award-info":[{"award-number":["NIHAYS2505"]}],"id":[{"id":"https:\/\/ror.org\/00xdrzy17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center","award":["GWJJMB202510025012"],"award-info":[{"award-number":["GWJJMB202510025012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00228-026-04180-x","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:12:13Z","timestamp":1790899933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalizing mycophenolate therapy: genetic determinants and practical limited sampling strategy for pediatric lupus nephritis"],"prefix":"10.1007","volume":"82","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9324-5490","authenticated-orcid":false,"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"4","key":"4180_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.rdc.2013.05.001","volume":"39","author":"M Bennett","year":"2013","unstructured":"Bennett M, Brunner HI (2013) Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am 39(4):833\u2013853. https:\/\/doi.org\/10.1016\/j.rdc.2013.05.001","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"4180_CR2","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1177\/09612033211028658","volume":"30","author":"KM Vazzana","year":"2021","unstructured":"Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C et al (2021) Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort. Lupus 30(10):1660\u20131670. https:\/\/doi.org\/10.1177\/09612033211028658","journal-title":"Lupus"},{"issue":"4","key":"4180_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/art.42375","volume":"75","author":"M Hocao\u01e7lu","year":"2023","unstructured":"Hocao\u01e7lu M, Valenzuela-Almada MO, Dabit JY, Osei-Onomah SA, Chevet B, Giblon RE et al (2023) Incidence, prevalence, and mortality of lupus nephritis: a population-based study over four decades using the lupus midwest network. Arthr Rheumatol (Hoboken, NJ) 75(4):567\u2013573. https:\/\/doi.org\/10.1002\/art.42375","journal-title":"Arthr Rheumatol (Hoboken, NJ)"},{"issue":"8","key":"4180_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00467-016-3437-y","volume":"32","author":"A Hackl","year":"2017","unstructured":"Hackl A, Ehren R, Weber LT (2017) Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells. Pediatr Nephrol (Berlin, Germany) 32(8):1315\u20131322. https:\/\/doi.org\/10.1007\/s00467-016-3437-y","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"issue":"11","key":"4180_CR5","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P et al (2017) European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis 76(11):1788\u20131796. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210960","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4180_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1592\/phco.29.1.7","volume":"29","author":"MS Joy","year":"2009","unstructured":"Joy MS, Hilliard T, Hu Y, Hogan SL, Dooley MA, Falk RJ et al (2009) Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy 29(1):7\u201316. https:\/\/doi.org\/10.1592\/phco.29.1.7","journal-title":"Pharmacotherapy"},{"issue":"15","key":"4180_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2217\/pgs-2021-0087","volume":"22","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Hu N (2021) Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients. Pharmacogenomics 22(15):1019\u20131040. https:\/\/doi.org\/10.2217\/pgs-2021-0087","journal-title":"Pharmacogenomics"},{"issue":"7\u20138","key":"4180_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cca.2011.12.003","volume":"413","author":"F Geng","year":"2012","unstructured":"Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi XJ et al (2012) The association of the UGT1A8, SLCO1B3 and ABCC2\/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals. Clinica Chimica Acta; Int J Clin Chem. 413(7\u20138):683\u201390. https:\/\/doi.org\/10.1016\/j.cca.2011.12.003","journal-title":"Clinica Chimica Acta; Int J Clin Chem."},{"issue":"5","key":"4180_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/ndt\/gfy284","volume":"35","author":"DYH Yap","year":"2020","unstructured":"Yap DYH, Tam CH, Yung S, Wong S, Tang CSO, Mok TMY et al (2020) Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis. Nephrol Dial 35(5):810\u2013818. https:\/\/doi.org\/10.1093\/ndt\/gfy284","journal-title":"Nephrol Dial"},{"issue":"3","key":"4180_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/jcph.1565","volume":"60","author":"J Benjanuwattra","year":"2020","unstructured":"Benjanuwattra J, Pruksakorn D, Koonrungsesomboon N (2020) Mycophenolic acid and its pharmacokinetic drug-drug interactions in humans: review of the evidence and clinical implications. J Clin Pharmacol 60(3):295\u2013311. https:\/\/doi.org\/10.1002\/jcph.1565","journal-title":"J Clin Pharmacol"},{"issue":"Si2","key":"4180_CR11","doi-asserted-by":"publisher","first-page":"Si180","DOI":"10.1093\/rheumatology\/keae264","volume":"63","author":"L Zhang","year":"2024","unstructured":"Zhang L, Chen L, Liu X, Huang Z, Zheng Y, Tang K et al (2024) Optimal exposure of mycophenolic acid for induction therapy of childhood lupus nephritis patients: an observational cohort study. Rheumatology (Oxford) 63(Si2):Si180\u2013Si187. https:\/\/doi.org\/10.1093\/rheumatology\/keae264","journal-title":"Rheumatology (Oxford)"},{"key":"4180_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152674","volume":"72","author":"L Chen","year":"2025","unstructured":"Chen L, Zhang L, Liu B, Liu X, Huang Z, Tang K et al (2025) Exposure-response relationship of mycophenolic acid in pediatric lupus nephritis patients receiving multi-target therapy: An observational cohort study. Semin Arthritis Rheum 72:152674. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152674","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"4180_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I et al (2020) 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79(6):713\u2013723. https:\/\/doi.org\/10.1136\/annrheumdis-2020-216924","journal-title":"Ann Rheum Dis"},{"key":"4180_CR14","first-page":"1729","volume":"18","author":"J-W Huang","year":"2011","unstructured":"Huang J-W, Liu Y-F, Li J-L, Wang L, Wang C, Zhong G et al (2011) Development and application of HPLC method in simultaneous determination of mycophenolic acid and its 7-O-glucuronide metabolite in human plasma. Chin J Prim Med Pharm. 18:1729\u201331","journal-title":"Chin J Prim Med Pharm."},{"issue":"5","key":"4180_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/aps.2015.7","volume":"36","author":"XC Xie","year":"2015","unstructured":"Xie XC, Li J, Wang HY, Li HL, Liu J, Fu Q et al (2015) Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients. Acta Pharmacol Sin 36(5):644\u2013650. https:\/\/doi.org\/10.1038\/aps.2015.7","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"4180_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/ftd.0000000000000871","volume":"43","author":"S Bergan","year":"2021","unstructured":"Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F et al (2021) Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 43(2):150\u2013200. https:\/\/doi.org\/10.1097\/ftd.0000000000000871","journal-title":"Ther Drug Monit"},{"issue":"3","key":"4180_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/sj.tpj.6500473","volume":"8","author":"E Sandanaraj","year":"2008","unstructured":"Sandanaraj E, Jada SR, Shu X, Lim R, Lee SC, Zhou Q et al (2008) Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients. Pharmacogenomics J 8(3):174\u2013185. https:\/\/doi.org\/10.1038\/sj.tpj.6500473","journal-title":"Pharmacogenomics J"},{"key":"4180_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.605060","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Sun L, Xu H, Dong M, Mizuno T, Vinks AA et al (2020) PK\/PD Study of Mycophenolate Mofetil in children with systemic lupus erythematosus to inform model-based precision dosing. Front Pharmacol 11:605060. https:\/\/doi.org\/10.3389\/fphar.2020.605060","journal-title":"Front Pharmacol"},{"issue":"1s","key":"4180_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"105","author":"BH Rovin","year":"2024","unstructured":"Rovin BH, Ayoub IM, Chan TM, Liu ZH, Mej\u00eda-Vilet JM, Floege J (2024) KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int. 105(1s):S1-s69. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002","journal-title":"Kidney Int."},{"issue":"2","key":"4180_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH (2020) Update on Lupus Nephritis: Core Curriculum 2020. Am J Kidney Dis 76(2):265\u2013281. https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.017","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"4180_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00906-7","volume":"22","author":"M Kostopoulou","year":"2020","unstructured":"Kostopoulou M, Adamichou C, Bertsias G (2020) An update on the diagnosis and management of lupus nephritis. Curr Rheumatol Rep 22(7):30. https:\/\/doi.org\/10.1007\/s11926-020-00906-7","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"4180_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/2175-8239-jbn-2018-0097","volume":"41","author":"SVB Pinheiro","year":"2019","unstructured":"Pinheiro SVB, Dias RF, Fabiano RCG, Araujo SA, Silva A (2019) Pediatric lupus nephritis. Jornal brasileiro de nefrologia: \u2019orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 41(2):252\u2013265. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2018-0097","journal-title":"Jornal brasileiro de nefrologia: 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia"},{"issue":"1","key":"4180_CR23","first-page":"91","volume":"55","author":"LT Weber","year":"2003","unstructured":"Weber LT, H\u00f6cker B, Mehls O, T\u00f6nshoff B (2003) Mycophenolate mofetil in pediatric renal transplantation. Minerva urologica e nefrologica. 55(1):91\u20139","journal-title":"Minerva urologica e nefrologica."},{"issue":"11","key":"4180_CR24","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/jcph.745","volume":"56","author":"D Zhang","year":"2016","unstructured":"Zhang D, Renbarger JL, Chow DS (2016) Pharmacokinetic variability of mycophenolic acid in pediatric and adult patients with hematopoietic stem cell transplantation. J Clin Pharmacol 56(11):1378\u20131386. https:\/\/doi.org\/10.1002\/jcph.745","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"4180_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/bcp.13154","volume":"83","author":"JT Tang","year":"2017","unstructured":"Tang JT, de Winter BC, Hesselink DA, Sombogaard F, Wang LL, van Gelder T (2017) The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients. Br J Clin Pharmacol 83(4):812\u2013822. https:\/\/doi.org\/10.1111\/bcp.13154","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 10","key":"4180_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/jcph.1284","volume":"58","author":"J van den Anker","year":"2018","unstructured":"van den Anker J, Reed MD, Allegaert K, Kearns GL (2018) Developmental Changes in Pharmacokinetics and Pharmacodynamics. J Clin Pharmacol 58(Suppl 10):S10-s25. https:\/\/doi.org\/10.1002\/jcph.1284","journal-title":"J Clin Pharmacol"},{"issue":"19","key":"4180_CR27","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ajhp\/zxz161","volume":"76","author":"SY Lim","year":"2019","unstructured":"Lim SY, Pettit RS (2019) Pharmacokinetic considerations in pediatric pharmacotherapy. Am J Health Syst Pharm 76(19):1472\u20131480. https:\/\/doi.org\/10.1093\/ajhp\/zxz161","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"4180_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/cpt.1109","volume":"105","author":"DK Bhatt","year":"2019","unstructured":"Bhatt DK, Mehrotra A, Gaedigk A, Chapa R, Basit A, Zhang H et al (2019) Age- and genotype-dependent variability in the protein abundance and activity of six major uridine diphosphate-glucuronosyl transferases in human liver. Clin Pharmacol Ther 105(1):131\u2013141. https:\/\/doi.org\/10.1002\/cpt.1109","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 2","key":"4180_CR29","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.21037\/tau.2018.10.16","volume":"8","author":"AR Cossart","year":"2019","unstructured":"Cossart AR, Cottrell WN, Campbell SB, Isbel NM, Staatz CE (2019) Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients. Transl Androl Urol 8(Suppl 2):S198-s213. https:\/\/doi.org\/10.21037\/tau.2018.10.16","journal-title":"Transl Androl Urol"},{"issue":"6","key":"4180_CR30","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10157-018-1590-2","volume":"22","author":"T Katsuno","year":"2018","unstructured":"Katsuno T, Ozaki T, Ozeki T, Hachiya A, Kim H, Kato N et al (2018) Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis. Clin Exp Nephrol 22(6):1341\u20131350. https:\/\/doi.org\/10.1007\/s10157-018-1590-2","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"4180_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/00007691-199412000-00012","volume":"16","author":"LJ Langman","year":"1994","unstructured":"Langman LJ, LeGatt DF, Yatscoff RW (1994) Blood distribution of mycophenolic acid. Ther Drug Monit 16(6):602\u2013607. https:\/\/doi.org\/10.1097\/00007691-199412000-00012","journal-title":"Ther Drug Monit"},{"issue":"6","key":"4180_CR32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1345\/aph.1L699","volume":"43","author":"MS Joy","year":"2009","unstructured":"Joy MS, Hilliard T, Hu Y, Hogan SL, Wang J, Falk RJ et al (2009) Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother 43(6):1020\u20131027. https:\/\/doi.org\/10.1345\/aph.1L699","journal-title":"Ann Pharmacother"},{"issue":"5","key":"4180_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1248\/bpb.34.755","volume":"34","author":"Y Mino","year":"2011","unstructured":"Mino Y, Naito T, Shimoyama K, Ogawa N, Kawakami J (2011) Pharmacokinetic variability of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in remission maintenance phase. Biol Pharm Bull 34(5):755\u2013759. https:\/\/doi.org\/10.1248\/bpb.34.755","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"4180_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/ng.307","volume":"41","author":"J Erdmann","year":"2009","unstructured":"Erdmann J, Grosshennig A, Braund PS, K\u00f6nig IR, Hengstenberg C, Hall AS et al (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 41(3):280\u20132. https:\/\/doi.org\/10.1038\/ng.307","journal-title":"Nat Genet."},{"issue":"5","key":"4180_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10528-016-9746-9","volume":"54","author":"S Shahzadi","year":"2016","unstructured":"Shahzadi S, Shabana, Chaudhry M, Arooj I, Hasnain S (2016) A single-nucleotide polymorphism in C12orf43 region is associated with the risk of coronary artery disease in a Pakistani cohort. Biochem Genet. 54(5):676\u201384. https:\/\/doi.org\/10.1007\/s10528-016-9746-9","journal-title":"Biochem Genet."},{"issue":"4","key":"4180_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/acr2.1035","volume":"1","author":"EY Sun","year":"2019","unstructured":"Sun EY, Alvarez C, Sheikh SZ (2019) Association of lupus nephritis with coronary artery disease by ISN\/RPS classification: results from a large real-world lupus population. ACR Open Rheumatol 1(4):244\u2013250. https:\/\/doi.org\/10.1002\/acr2.1035","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"4180_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05785-8","volume":"45","author":"L Zinglersen","year":"2025","unstructured":"Zinglersen L, Zinglersen AH, Myhr KA, Hermansen ML, Kofoed KF, Fuchs A et al (2025) Coronary artery calcification progression and renal involvement in patients with systemic lupus erythematosus: a longitudinal cohort study. Rheumatol Int 45(1):26. https:\/\/doi.org\/10.1007\/s00296-025-05785-8","journal-title":"Rheumatol Int"},{"issue":"3","key":"4180_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106974","volume":"32","author":"Y Li","year":"2023","unstructured":"Li Y, You C, Liu Z, He F, Zhao F, Song X et al (2023) CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage. J Stroke Cerebrovasc Dis 32(3):106974. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2022.106974","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"4180_CR39","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1097\/TP.0b013e3182488bb4","volume":"93","author":"R Bouamar","year":"2012","unstructured":"Bouamar R, Elens L, Shuker N, van Schaik RH, Weimar W, Hesselink DA et al (2012) Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8. Transplantation 93(10):e39-40. https:\/\/doi.org\/10.1097\/TP.0b013e3182488bb4","journal-title":"Transplantation"},{"issue":"3","key":"4180_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/TP.0b013e318200e971","volume":"91","author":"PA Jacobson","year":"2011","unstructured":"Jacobson PA, Schladt D, Oetting WS, Leduc R, Guan W, Matas AJ et al (2011) Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation. Transplant 91(3):309\u2013316. https:\/\/doi.org\/10.1097\/TP.0b013e318200e971","journal-title":"Transplant"},{"issue":"1","key":"4180_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13227-0","volume":"24","author":"Q Ji","year":"2024","unstructured":"Ji Q, Hu Y, Liu M, Liu L, Zheng J, Du Z et al (2024) Post-transplant complications revealed by mycophenolate mofetil related transporters and metabolic enzymes gene polymorphisms in pediatric patients with hematological disorders. BMC Cancer 24(1):1516. https:\/\/doi.org\/10.1186\/s12885-024-13227-0","journal-title":"BMC Cancer"},{"issue":"1","key":"4180_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.abb.2012.04.010","volume":"522","author":"MK Ross","year":"2012","unstructured":"Ross MK, Borazjani A, Wang R, Crow JA, Xie S (2012) Examination of the carboxylesterase phenotype in human liver. Arch Biochem Biophys 522(1):44\u201356. https:\/\/doi.org\/10.1016\/j.abb.2012.04.010","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"4180_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4014\/jmb.2306.06020","volume":"34","author":"Q Xie","year":"2024","unstructured":"Xie Q, Cao Z, You W, Cai X, Shen M, Yin Z et al (2024) Ganodermanontriol suppresses the progression of lung adenocarcinoma by activating CES2 to enhance the metabolism of mycophenolate mofetil. J Microbiol Biotechnol 34(2):249\u2013261. https:\/\/doi.org\/10.4014\/jmb.2306.06020","journal-title":"J Microbiol Biotechnol"},{"issue":"Pt B","key":"4180_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mrgentox.2018.06.008","volume":"836","author":"HL Cili\u00e3o","year":"2018","unstructured":"Cili\u00e3o HL, Camargo-Godoy RBO, Souza MF, Zanuto A, Delfino VDA, C\u00f3lus IMS (2018) Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil. Mutat Res Genet Toxicol Environ Mutagen 836(Pt B):97\u2013102. https:\/\/doi.org\/10.1016\/j.mrgentox.2018.06.008","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"4180_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001535","author":"C Ye","year":"2025","unstructured":"Ye C, Liu B, Chen L, Zhang L, Zheng Y, Tang K et al (2025) Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2025-001535","journal-title":"Lupus Sci Med"},{"issue":"5","key":"4180_CR46","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/bcp.12678","volume":"80","author":"AN Abd Rahman","year":"2015","unstructured":"Abd Rahman AN, Tett SE, Abdul Gafor HA, McWhinney BC, Staatz CE (2015) Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis. Br J Clin Pharmacol 80(5):1064\u20131075. https:\/\/doi.org\/10.1111\/bcp.12678","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"4180_CR47","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/ndt\/gfu184","volume":"30","author":"T van Gelder","year":"2015","unstructured":"van Gelder T, Berden JH, Berger SP (2015) To TDM or not to TDM in lupus nephritis patients treated with MMF? Nephrol Dial Transplant 30(4):560\u2013564. https:\/\/doi.org\/10.1093\/ndt\/gfu184","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"4180_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/FTD.0b013e31818b8244","volume":"30","author":"Y Mino","year":"2008","unstructured":"Mino Y, Naito T, Matsushita T, Otsuka A, Ushiyama T, Ozono S et al (2008) Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation. Ther Drug Monit 30(6):656\u2013661. https:\/\/doi.org\/10.1097\/FTD.0b013e31818b8244","journal-title":"Ther Drug Monit"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04180-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:27:45Z","timestamp":1791275265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04180-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4180"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04180-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The hospital ethics committee approved the protocol on September 23, 2021 (No. 2021493), and written informed consent was obtained from all participants' parents\/guardians.","order":1,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that the research was conducted in the absence of any financial or non-financial interests that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"262"}}